US Patent 9987270 Treatment of gliomas using organonitro compound combination therapy
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+230 characters)
Article
Patent abstract
The invention provides therapeutic methods and kits for treating a glioma using a particular dosing regimen of the organonitro compound ABDNAZ, radiation therapy, and one of temozolomide, irinotecan, or bevacizumab.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Bryan T. Oronsky0
Jan Scicinski0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09987270 Treatment of gliomas using organonitro compound combination therapy US Patent 9987270 Treatment of gliomas using organonitro compound combination therapy
Infobox
Patent Number
09987270
Patent Number
9987270
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09987270 Treatment of gliomas using organonitro compound combination therapy
Infobox
Is a
Patent jurisdiction
Patent number
09987270
Date of patent
June 5, 2018
Patent application number
15337378
Date Filed
October 28, 2016
Patent primary examiner
Find more entities like US Patent 9987270 Treatment of gliomas using organonitro compound combination therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
